US · Healthcare

Galera Therapeutics Inc (GRTX)

Biotechnology

Galera Therapeutics Inc (GRTX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GRTX

P/E ratio

25.00

Galera Therapeutics Inc (GRTX) — FAQ

What is GRTX's P/E ratio?

The price-to-earnings (P/E) ratio for Galera Therapeutics Inc (GRTX) is 25.00 (data as of 2026-05-23).

Does Galera Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Galera Therapeutics Inc (GRTX). Check the MyAverix Finance app for the latest dividend data.

What sector is Galera Therapeutics Inc in?

Galera Therapeutics Inc (GRTX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GRTX listed on?

GRTX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)